Type
1.
Yunzhi, Yue, Lili, Zhonghe, Lianhua, Ying, et al. Dental health and treatment needs in people with leprosy in China. Leprosy review [Internet]. 2014;85(4):311-2. Available from: https://leprosyreview.org/article/85/4/31-1321
Type
1.
Rawson, Anjum, Hodgson, Rao, Murthy K, Rao, et al. Leprosy and tuberculosis concomitant infection: A poorly understood, age-old relationship. Leprosy review [Internet]. 2014;85(4):288-95. Available from: https://leprosyreview.org/article/85/4/28-8295
Type
1.
Ferreira IPS, Bührer-Sékula S, Fernandes De Oliveira ME, De Sa Concalves H, Pontes MAA, Penna MLF Universidade Federal Fluminense Departamento de Epidemiologia e Bioestatistica, et al. Patient profile and treatment satisfaction of Brazilian leprosy patients in a clinical trial of uniform six-month multidrug therapy (U-MDT/CT-BR). Leprosy review [Internet]. 2014;85(4):267-74. Available from: https://leprosyreview.org/article/85/4/26-7274
Type
1.
Talhari C, Talhari S, Penna GO. Clinical aspects of leprosy. Clinics in dermatology. 2015;33(1):26-37.
Type
1.
Almeida-Neto, Assis Costa, Oliveira-Filho, Souza Franco, ão de Lima, Barros de Lorena, et al. TH17 cells, interleukin-17 and interferon- γ in patients and households contacts of leprosy with multibacillary and paucibacillary forms before and after the start of chemotherapy treatment. Journal of the European Academy of Dermatology and Venereology. 2014;.
Type
1.
Hooper P, Chu B, Mikhailov A, Ottesen E, Bradley M. Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis. PLoS neglected tropical diseases [Internet]. 2014;8(11):e3333. Available from: http://www.plosntds.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pntd.0003333&representation=PDF
Type
1.
Kabatereine N, Fleming F, Thuo W, Tinkitina B, Tukahebwa E, Fenwick A. Community perceptions, attitude, practices and treatment seeking behaviour for schistosomiasis in L. Victoria islands in Uganda. BMC research notes [Internet]. 2014;7(1):22 p. Available from: http://www.biomedcentral.com/content/pdf/1756-0500-7-900.pdf
Type
1.
Rilkoff H, Tukahebwa EM, Fleming F, Leslie J, Cole D. Exploring gender dimensions of treatment programmes for neglected tropical diseases in Uganda. PLoS neglected tropical diseases [Internet]. 2013;7(7):e2312. Available from: http://www.plosntds.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pntd.0002312&representation=PDF
Type
1.
Makenga Bof, Maketa, Bakajika, Ntumba, Mpunga, Murdoch, et al. Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment. Tropical medicine & international health : TM & IH. 2015;20(1):48-62.
Type
1.
Coffeng L, Stolk W, Hoerauf A, Habbema D, Bakker R, Hopkins A, et al. Elimination of African onchocerciasis: Modeling the impact of increasing the frequency of Ivermectin mass treatment. PloS one [Internet]. 2014;9(12):e115886. Available from: http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0115886&representation=PDF